【导读】深圳证监局下发《行政监管措施决定书》，查明全新好存在四项问题 12月11日晚间，全新好发布公告称，深圳证监局近日下发的《中国证券监督管理委员会深圳监管局行政监管措施决定 书》，认定公司存在四项问题，涉及财务核算、信息披露、内部控制、公司治理等方面。 12月11日收盘，全新好股价报10.09元/股，跌幅达1.56%，总市值为34.96亿元。 四是公司治理不规范。全新好未与部分董事签订合同、未及时修订完善内幕信息知情人登记管理制度、未对个别重大事项 制作内幕信息知情人档案，内幕信息知情人未对内幕信息知情人档案进行确认。 监管查明全新好存在四项问题 一是财务核算不规范。2022年至2024年，全新好的房屋租赁业务，在财务核算上未考虑免租期影响；外销业务收入确认时 点与披露政策不符且存在跨期情形；外销杀菌纸巾业务收入确认不规范。 全新好的上述情形不符合《企业会计准则第21号——租赁》第四十五条、《企业会计准则第14号——收入》第四条、第十 三条、第三十四条的规定。 二是信息披露不规范。因对杀菌纸巾和其他日常用品分类错误，全新好2023年、2024年年报对杀菌纸巾和其他日常用品的 收入披露错误，不符合《上市公司 ...

【 导读 】 深圳证监局下发《行政监管措施决定书》，查明全新好存在四项问题 中国基金报记者 闻言 12月11日晚间，全新好发布公告称，深圳证监局近日下发的《中国证券监督管理委员会深圳监管局行政监管措施决定书》，认定公司存在 四项问题，涉及财务核算、信息披露、内部控制、公司治理等方面。 二是信息披露不规范。因对杀菌纸巾和其他日常用品分类错误，全新好2023年、2024年年报对杀菌纸巾和其他日常用品的收入披露错误， 不符合《上市公司信息披露管理办法》（证监会令第182号，下同）第三条第一款的规定。 三是内部控制不规范。全新好对其孙公司江门市都合纸业科技有限公司的管控不到位，不符合《企业内部控制应用指引第1号——组织架 构》第十条的规定。 四是公司治理不规范。全新好未与部分董事签订合同、未及时修订完善内幕信息知情人登记管理制度、未对个别重大事项制作内幕信息知 情人档案，内幕信息知情人未对内幕信息知情人档案进行确认。 深圳证监局 表示 ，全新好被查明的情况，反映其在财务核算、信息披露、内部控制、公司治理等方面存在问题，其中财务核算问题影响相 关财务信息披露的准确性。 12月11日收盘，全新好股价报10.09元/股，跌 ...

Core Viewpoint - The company, Furu Pharmaceutical (300049.SZ), has received a decision from the Inner Mongolia Regulatory Bureau of the China Securities Regulatory Commission, indicating several compliance issues related to internal controls and revenue recognition practices [1][2]. Group 1: Internal Control Issues - The company lacks a comprehensive internal control and risk management system for its important overseas subsidiaries, failing to meet the requirements set forth in the Corporate Governance Guidelines [1]. - Internal departments have not conducted inspections and supervision of overseas subsidiaries, which is also a violation of regulatory standards [1]. Group 2: Revenue Recognition Issues - The company has prematurely recognized revenue from drug sales, resulting in the following overstatements: CNY 2.4089 million for the 2023 semi-annual report, CNY 2.8810 million for the 2023 annual report, CNY 5.6703 million for the 2024 semi-annual report, and CNY 1.3417 million for the 2024 annual report, affecting the accuracy of financial disclosures [2]. - In June 2023, the company fully recognized revenue from a drug sale that included a return clause, but failed to account for the return when it occurred in August, leading to inaccuracies in the 2023 semi-annual report [2]. - The company did not reasonably estimate variable consideration such as sales discounts and rebates in its accounting for 2023 and 2024, resulting in full revenue recognition without appropriate adjustments when discounts were paid [2].

Core Viewpoint - Wuzhou Transportation has received regulatory measures from the Guangxi Securities Regulatory Bureau due to issues related to accounting irregularities and failure to conduct integrity checks on proposed senior management appointments [1][2]. Group 1: Regulatory Actions - The Guangxi Securities Regulatory Bureau issued a corrective order to Wuzhou Transportation for non-compliance with accounting standards and improper revenue recognition practices from 2022 to 2024 [1]. - The company failed to conduct required integrity checks on proposed directors and senior management, violating relevant regulations [1]. Group 2: Company Response - Wuzhou Transportation emphasizes its commitment to addressing the issues raised by the regulatory body and plans to enhance its financial management and compliance practices [2]. - The company will prepare a rectification report within the stipulated timeframe as per the regulatory requirements [2]. Group 3: Business Overview - Wuzhou Transportation is the only listed company in Guangxi operating toll road businesses, with significant operations in toll collection and logistics [3]. - For the first three quarters of 2025, the company reported a revenue of 1.205 billion yuan, a decrease of 0.86% year-on-year, and a net profit of 508 million yuan, down 10.26% year-on-year [3].

Core Viewpoint - Guangdong Marubi Biotechnology Co., Ltd. has been issued an administrative regulatory decision by the Guangdong Securities Regulatory Commission due to irregularities in financial accounting, fundraising management, and disclosure practices [2][4][6]. Financial Accounting Irregularities - The company has been found to have inaccurate revenue accounting, failing to estimate return rates based on actual sales returns and including non-actual sales orders in revenue [4]. - There were inaccuracies in the accounting of construction in progress, with the company not timely estimating unbilled construction payments and failing to transfer assets to fixed assets upon completion [4]. - Errors in accounting classifications were noted, such as misreporting funds held in third-party payment platforms as accounts receivable and misclassifying unrelated consulting fees as research and development expenses [4]. Fundraising Management and Disclosure Issues - The company improperly used fundraising and self-owned funds for the construction of its headquarters without separating the accounting for fundraising projects from non-fundraising projects [5]. - Adjustments to fundraising projects were not timely reviewed and disclosed, leading to discrepancies between reported project progress and actual status [5]. - The company failed to disclose relevant information regarding cash management of fundraising, including returns on financial products and investment details [5]. Regulatory Actions - The chairman, board secretary, and financial director of the company have been held primarily responsible for the violations and have received warning letters from the regulatory authority [6]. Financial Statement Corrections - The company announced corrections to its financial statements for the first half of 2025, revealing inflated figures in various financial metrics, including an increase in operating income by 4.5468 million and net profit by 11.3297 million [7][10]. - The corrected balance sheet showed an overstatement of construction in progress by 568 million and underreported fixed assets and investment properties by 375 million and 183 million, respectively [10]. Recent Financial Performance - For the third quarter of 2025, the company reported operating revenue of 2.45 billion, a year-on-year increase of 25.5%, while net profit attributable to shareholders was 244 million, up 2.1% year-on-year [10].

Core Viewpoint - Beijing Hanjian Heshan Pipeline Co., Ltd. received an administrative supervision measure from the Beijing Securities Regulatory Bureau, requiring the company to rectify issues related to financial accounting, information disclosure, and compliance with regulations [1][2]. Summary by Sections Overall Rectification Arrangement - The company has taken the issues raised in the decision seriously and has communicated them to all board members, supervisors, and senior management. A comprehensive review and analysis of the matters have been conducted, and rectification plans have been proposed [2]. Issues and Measures Ordered for Rectification Issue 1: Non-compliance in Financial Accounting - Problems identified include inaccurate revenue recognition for a project, incorrect write-offs of accounts receivable, and inadequate impairment provisions for construction costs and goodwill [3]. - Rectification measures include holding meetings to approve corrections of prior accounting errors, enhancing financial personnel's understanding of revenue standards, and improving internal controls and audit processes [4][5][6]. Issue 2: Non-compliance in Disclosing Major Litigation - The company failed to timely disclose a cumulative litigation amount of 122 million yuan over 12 months [7]. - Measures taken include establishing a litigation case management system, improving internal communication regarding significant information, and enhancing compliance awareness among management [8][9][10]. Issue 3: Non-compliance in Disclosing Related Transactions - The company did not follow proper procedures for disclosing related transactions totaling 65.63 million yuan over 12 months [11]. - Rectification actions involve confirming related transactions, conducting compliance training, and strengthening internal management regarding related party transactions [12][14][15]. Summary of Rectification Status - The company acknowledges the issues in financial accounting and information disclosure and emphasizes the importance of compliance for sustainable development. It aims to enhance the awareness of regulatory compliance among its management and improve the quality of information disclosure [16].

Core Viewpoint - Beijing Hanjian Heshan Pipeline Co., Ltd. (Hanjian Heshan) has received an administrative regulatory measure from the Beijing Securities Regulatory Bureau due to multiple violations, including improper financial accounting, failure to disclose significant litigation, and non-compliance in disclosing related party transactions [1][2]. Group 1: Regulatory Violations - The company was found to have improper financial accounting practices, including inaccurate revenue recognition for a project in Guangxi, leading to discrepancies in financial statements [1]. - Hanjian Heshan failed to disclose significant litigation, with a total involved amount of 122 million yuan over the past 12 months, and did not report this in its interim report for 2023 [1]. - The company did not properly disclose related party transactions, totaling 65.63 million yuan over the past 12 months, and failed to follow required review procedures and timely information disclosure obligations [1]. Group 2: Regulatory Actions - The Beijing Securities Regulatory Bureau has issued a warning letter to Hanjian Heshan and its key personnel, which will be recorded in the capital market integrity file [2]. - The responsible individuals are required to submit a written rectification report within 15 working days from the receipt of the decision [2]. Group 3: Company Performance - Since August, Hanjian Heshan's stock price has been on a decline, closing at 5.22 yuan per share on September 25, down 1.88% [3].

Core Viewpoint - The company, Han Jian He Shan, has received a warning letter from the Beijing Securities Regulatory Bureau due to various regulatory violations, including improper financial accounting and failure to disclose significant lawsuits and related party transactions in a timely manner [1][2]. Financial Violations - The company was found to have non-compliant financial accounting practices, including incorrect revenue recognition for a project in Guangxi, leading to inaccuracies in income and other financial statement items [1] - There were inaccuracies in the write-off of accounts receivable and the aging calculation, resulting in incorrect provisions for bad debts [1] - The impairment provisions for construction contracts were also inaccurately calculated, and the reasons for changes in asset group scope during goodwill impairment testing were not clearly stated [1] Disclosure Issues - Han Jian He Shan failed to timely disclose significant lawsuits, with a total involved amount of 122 million yuan over the past 12 months, which was not reported in the interim report for the first half of 2023 [1] - The company also did not properly disclose related party transactions, totaling 65.63 million yuan over the past 12 months, and failed to follow required review procedures and timely information disclosure obligations [1] Company Overview - Han Jian He Shan was established on July 7, 2004, and was listed on the Shanghai Stock Exchange in June 2015. The company specializes in the research, production, and sales of prestressed concrete pipes (PCCP), reinforced concrete drainage pipes (RCP), and ready-mixed concrete [4] - In the first half of 2023, the company reported a revenue of 310 million yuan, representing a year-on-year increase of 103.08%, and a net profit attributable to shareholders of 6.38 million yuan, up 118.71% year-on-year [4] - As of September 25, 2023, the company's stock price was 5.22 yuan per share, reflecting a decline of 1.88% [4]

Group 1 - The company has violated multiple regulations as per the Stock Listing Rules and Self-Regulatory Guidelines, indicating a need for strict adherence to legal and regulatory obligations [1] - The company is urged to ensure accurate, complete, and timely information disclosure to prevent future occurrences of similar issues [1] - For the first half of 2025, the revenue composition of the company is as follows: waterproof materials sales account for 69.71%, mortar powder accounts for 14.71%, other sales account for 8.39%, waterproof engineering construction accounts for 6.26%, and other businesses account for 0.94% [1] Group 2 - On August 11, 2025, the Shenzhen Stock Exchange issued a regulatory letter to the company regarding financial accounting irregularities, including inaccurate revenue recognition and improper accounting practices [3] - Specific issues identified include the use of total amount method for photovoltaic component sales, incorrect timing for revenue recognition on engineering projects, and improper accounting for debt restructuring of certain assets [3] - The company has also been noted for improper use of advance payments to offset accounts receivable and errors in the aging classification of other receivables [3]

Core Points - The company has not faced any penalties from regulatory authorities in the last five years [1][6] - The company has been subject to regulatory measures due to inconsistencies in accounting practices and internal controls [2][4][5] Regulatory Measures - The company was ordered to rectify issues related to revenue recognition timing, which did not align with disclosed accounting policies [2][4] - There were problems with the accounting for upgrade and transformation service costs, leading to mismatched income and costs [2][3] - Insufficient basis for inventory impairment provisions was noted, with arbitrary adjustments in different years [2][3] - Inaccurate accounting for construction in progress and production debugging costs was identified [2][3] Responsibilities and Actions - The chairman and financial officer were held primarily responsible for the identified issues and received warning letters from the regulatory authority [4][5] - The company acknowledged the need for improvement in governance, internal controls, and financial management practices [5][6] - The company plans to enhance training for board members and financial personnel to improve compliance and operational standards [5][6]